BR112013014616A2 - sistema terapêutico transdérmico para a administração de uma substância ativa - Google Patents

sistema terapêutico transdérmico para a administração de uma substância ativa

Info

Publication number
BR112013014616A2
BR112013014616A2 BR112013014616A BR112013014616A BR112013014616A2 BR 112013014616 A2 BR112013014616 A2 BR 112013014616A2 BR 112013014616 A BR112013014616 A BR 112013014616A BR 112013014616 A BR112013014616 A BR 112013014616A BR 112013014616 A2 BR112013014616 A2 BR 112013014616A2
Authority
BR
Brazil
Prior art keywords
administration
active substance
therapeutic system
transdermal therapeutic
transdermal
Prior art date
Application number
BR112013014616A
Other languages
English (en)
Other versions
BR112013014616B1 (pt
Inventor
Bjoern Schurad
Britta Langer
Heike Prinz
Original Assignee
Acino Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acino Ag filed Critical Acino Ag
Publication of BR112013014616A2 publication Critical patent/BR112013014616A2/pt
Publication of BR112013014616B1 publication Critical patent/BR112013014616B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112013014616-8A 2010-12-14 2011-12-14 Sistema terapêutico transdérmico para administração de rivastigmina através da pele, e seu processo de produção BR112013014616B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10194968.3 2010-12-14
EP10194968.3A EP2468274B1 (de) 2010-12-14 2010-12-14 Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs
PCT/EP2011/072812 WO2012080365A1 (de) 2010-12-14 2011-12-14 Transdermales therapeutisches system zur verabreichung eines wirkstoffs

Publications (2)

Publication Number Publication Date
BR112013014616A2 true BR112013014616A2 (pt) 2016-09-20
BR112013014616B1 BR112013014616B1 (pt) 2021-12-21

Family

ID=43836835

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013014616-8A BR112013014616B1 (pt) 2010-12-14 2011-12-14 Sistema terapêutico transdérmico para administração de rivastigmina através da pele, e seu processo de produção

Country Status (25)

Country Link
US (2) US10660863B2 (pt)
EP (2) EP2468274B1 (pt)
JP (1) JP6043296B2 (pt)
KR (1) KR101842309B1 (pt)
CN (3) CN103269698B (pt)
AU (2) AU2011343363B2 (pt)
BR (1) BR112013014616B1 (pt)
CA (2) CA3065240C (pt)
CY (2) CY1116638T1 (pt)
DK (2) DK2468274T3 (pt)
EA (1) EA026520B1 (pt)
ES (2) ES2545094T3 (pt)
HK (1) HK1243336A1 (pt)
HR (2) HRP20150881T1 (pt)
HU (2) HUE027916T2 (pt)
LT (1) LT2651410T (pt)
MX (1) MX345344B (pt)
MY (1) MY183873A (pt)
PL (2) PL2468274T3 (pt)
PT (2) PT2468274E (pt)
RS (2) RS54173B1 (pt)
SI (2) SI2468274T1 (pt)
SM (1) SMT201500184B (pt)
WO (1) WO2012080365A1 (pt)
ZA (1) ZA201303965B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012000369A1 (de) * 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
DE102012016317A1 (de) * 2012-08-14 2014-02-20 Jenabatteries GmbH Redox-Flow-Zelle zur Speicherung elektrischer Energie
US20150196515A1 (en) * 2012-08-15 2015-07-16 Dow Coming Corporation Multi-Layer Drug Delivery System
WO2014111790A2 (en) * 2013-01-15 2014-07-24 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
US20240082065A1 (en) * 2016-07-08 2024-03-14 Moteah Williams Waterproof and transparent wound barrier and method of manufacturing same
JP6864968B2 (ja) 2016-08-22 2021-04-28 救急薬品工業株式会社 貼付剤
WO2019017266A1 (ja) * 2017-07-19 2019-01-24 帝國製薬株式会社 リバスチグミン含有経皮吸収型製剤
DE102018120505A1 (de) * 2017-10-20 2019-04-25 Amw Gmbh Verhinderung der Kristallisation von Wirkstoffen in transdermalen Darreichungssystemen
DE102017127433A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
BR112020018300A2 (pt) * 2018-03-13 2020-12-22 Lts Lohmann Therapie-Systeme Ag Sistema terapêutico transdérmico compreendendo um polímero híbrido de silicone e acrílico
WO2019220697A1 (ja) * 2018-05-17 2019-11-21 パナソニックＩｐマネジメント株式会社 生体貼付け用選択透過膜、経皮吸収キットおよび美容方法
ES2923891T3 (es) 2018-08-08 2022-10-03 Danapak Flexibles As Películas y láminas mejoradas para usarse en el envase de compuestos reactivos
KR20200025888A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
KR20200025883A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
JP2022540145A (ja) * 2019-07-09 2022-09-14 エルテーエス ローマン テラピー－ジステーメ アーゲー アクリルポリマーを含む活性剤含有層及びシリコーンゲル接着剤を含む皮膚接触層を含む経皮治療システム
CN113616625B (zh) * 2021-08-26 2023-05-30 大连科翔科技开发有限公司 一种卡巴拉汀的长效透皮贴剂

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201906B (en) 1987-03-04 1991-01-28 Sandoz Ag Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
KR950702811A (ko) * 1992-08-25 1995-08-23 더블유. 클레어리 게리 프린트 경피약제투여장치(Printed Transdermal Drug Delivery Device)
JPH0912448A (ja) * 1995-04-28 1997-01-14 Read Chem Kk 薬物放出制御型経皮吸収製剤
GB9800526D0 (en) 1998-01-12 1998-03-11 Ciba Geigy Ag Organic compounds
US6348210B1 (en) * 1998-11-13 2002-02-19 Alza Corporation Methods for transdermal drug administration
DE19918106A1 (de) 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
DE10033853A1 (de) 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
DE10103860B4 (de) * 2001-01-30 2004-12-23 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
DE10141652B4 (de) 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
ES2385386T3 (es) * 2004-10-21 2012-07-24 Durect Corporation Sistemas de administración transdérmica
US8252320B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
TWI389709B (zh) 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
CN101351233A (zh) * 2005-12-30 2009-01-21 科洛普拉斯特公司 具有可塑的层作为皮肤接触表面的层状粘合构造
CN101304735A (zh) * 2006-01-12 2008-11-12 Lts勒曼治疗***股份公司 用于挥发性和/或热不稳定的物质的经皮治疗体系
AU2006343077B2 (en) 2006-05-08 2012-11-08 Teikoku Seiyaku Co., Ltd. Tansdermally absorbable preparation comprising anti-dementia agent
US9248104B2 (en) 2006-08-17 2016-02-02 Core Tech Solutions, Inc. Transdermal methods and systems for treating Alzheimer's disease
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
WO2009009651A1 (en) * 2007-07-10 2009-01-15 Agile Therapeutics, Inc. Dermal delivery device with ultrasonic weld
WO2009026135A2 (en) * 2007-08-17 2009-02-26 Alza Corporation Controlled transdermal bisoprolol delivery system
EP2255802B1 (en) * 2008-02-27 2018-01-17 Hisamitsu Pharmaceutical Co., Inc. Adhesive skin patch and packaged product
US20090291127A1 (en) * 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
JP2010126450A (ja) * 2008-11-25 2010-06-10 Lintec Corp 経皮吸収貼付剤
JP6083734B2 (ja) * 2009-12-22 2017-02-22 リュイェ ファーマ アーゲーＬｕｙｅ Ｐｈａｒｍａ ＡＧ リバスチグミンまたはその誘導体を投与するための経皮治療システム

Also Published As

Publication number Publication date
EA201300704A1 (ru) 2014-01-30
HRP20201880T1 (hr) 2021-02-05
ES2836483T3 (es) 2021-06-25
US20140323996A1 (en) 2014-10-30
EP2468274B1 (de) 2015-07-01
CA3065240A1 (en) 2012-06-21
PL2651410T3 (pl) 2021-03-08
DK2651410T3 (da) 2020-11-02
KR20130129988A (ko) 2013-11-29
ZA201303965B (en) 2014-09-25
CN103269698B (zh) 2017-07-14
SI2651410T1 (sl) 2021-01-29
RS61155B1 (sr) 2020-12-31
WO2012080365A1 (de) 2012-06-21
US20200289426A1 (en) 2020-09-17
CA3065240C (en) 2022-02-15
LT2651410T (lt) 2020-12-28
CN107412202A (zh) 2017-12-01
CN113244199A (zh) 2021-08-13
CN103269698A (zh) 2013-08-28
CY1123712T1 (el) 2022-03-24
AU2017213569B2 (en) 2019-04-11
KR101842309B1 (ko) 2018-03-26
PT2468274E (pt) 2015-09-21
SMT201500184B (it) 2015-09-07
MY183873A (en) 2021-03-17
CY1116638T1 (el) 2017-03-15
MX2013005581A (es) 2013-08-26
MX345344B (es) 2017-01-26
PT2651410T (pt) 2020-12-15
DK2468274T3 (en) 2015-08-31
CA2817461C (en) 2020-02-25
EA026520B1 (ru) 2017-04-28
SI2468274T1 (sl) 2015-10-30
PL2468274T3 (pl) 2015-11-30
RS54173B1 (en) 2015-12-31
US10660863B2 (en) 2020-05-26
HRP20150881T1 (hr) 2015-09-25
HUE027916T2 (en) 2016-11-28
JP2014503523A (ja) 2014-02-13
EP2651410A1 (de) 2013-10-23
AU2017213569A1 (en) 2017-08-31
HK1243336A1 (zh) 2018-07-13
EP2468274A1 (de) 2012-06-27
ES2545094T3 (es) 2015-09-08
CA2817461A1 (en) 2012-06-21
EP2651410B1 (de) 2020-10-14
JP6043296B2 (ja) 2016-12-14
BR112013014616B1 (pt) 2021-12-21
HUE052137T2 (hu) 2021-04-28
AU2011343363B2 (en) 2017-06-08
AU2011343363A1 (en) 2013-06-20

Similar Documents

Publication Publication Date Title
BR112013014616A2 (pt) sistema terapêutico transdérmico para a administração de uma substância ativa
SMT201500232B (it) Dispositivo per la somministrazione de farmaci
CO7000779A2 (es) Sistema de administración transdermica
CO6920282A2 (es) Dispositivo para inyección automática de dosis de fármaco
CU24166B1 (es) Dispositivo para inyección automática de dosis de fármaco
DK3527241T3 (da) Indretning til administration af lægemiddel
BR112012026686A2 (pt) fórmulas melhoradas para dispositivos médicos revestidos com droga
DK2652652T3 (da) Medikmentadministration
BR112012005629A2 (pt) sistema terapêutico transdérmico para administrar fentanila ou um análogo da mesma
HK1182015A1 (zh) 活性藥物化合物用於治療中樞神經系統病症的用途
DK2353632T3 (da) Medicinsk anordning til lokal lægemiddelafgivelse
CO6801718A2 (es) Composición terapéutica para el tratamiento de glioblastoma
CO7020911A2 (es) Sistema para la administración de fármacos
DK2621561T3 (da) Fleksibelt fastgørelsesmiddel til lægemiddeladministrationsanordning
IL236465A0 (en) Pharmaceutical composition for delayed release of active substances
EE201300004A (et) Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks
BR112012023973A2 (pt) sistema configurado para monitorar reanimação cardiopulmonar
CR20130174A (es) Sistema y composiciones mejorados para la administración transbucal de fármacos
EP2567710A4 (en) AQUEOUS PHARMACEUTICAL SYSTEM FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES ON THE NAILS
PL2872126T3 (pl) Plaster farmaceutyczny do przezskórnego podawania tapentadolu
BR112013013890A2 (pt) sistema de cateter para um injetor de agulha com uma agulha automática/extensão de barreira
FI20120260A (fi) Vaikuttavan aineen iontoforeettinen annostelujärjestelmä
PL2585445T3 (pl) Polimorfy aktywnego składnika farmaceutycznego
BR112014009547A2 (pt) composição farmacêutica para administração oral, e, sistema de liberação para a administração oral de uma composição farmacêutica bifásica
BR112013008937A2 (pt) dispositivo ativo estimulador da área perineal

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25D Requested change of name of applicant approved

Owner name: LUYE PHARMA AG. (DE)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/12/2011, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.